Abiomed gets US boost for two major cardiac devices
This article was originally published in Clinica
Executive Summary
In what represents two key developments for the company, Abiomed has gained US market approval for a major new addition to its commercial product portfolio and has received a favourable decision from the FDA regarding its replacement heart, Abiocor.